The study found, three weeks after expectant moms got the vaccine against H1N1, 98 percent of them had developed protective levels of antibodies against the virus. And, when their babies were born, 95 percent of them had enough antibodies to be considered protected as well.
Researchers say vaccination during pregnancy protects infants during the first months of life when vaccination cannot be performed.
